Real-World Insights Into Acute promyelocytic leukemia (APL) in Egypt in the Absence of Arsenic Trioxide (ATO): Clinical Characteristics, Outcomes and Risk Factors for Early Mortality: A Single Center Study

Key Points

• Acute promyelocytic leukemia patients showed significant early mortality rates, indicating the need for immediate interventions.
• The study involved assessing clinical characteristics and outcomes among patients lacking arsenic trioxide treatment, revealing critical insights.
• Observational analysis at a single center in Egypt highlighted various risk factors associated with early mortality.
• These findings support the necessity for tailored treatment options in regions where arsenic trioxide is unavailable.